IDEXX LABORATORIES INC /DE (IDXX)
In Vitro & In Vivo Diagnostic Substances · In Vitro & In Vivo Diagnostic Substances · NASDAQ
$538.99
-1.13%
Investru Score
62.5 / 100
Good
Why is IDXX moving?
IDXX is down 1.13% today, in line with its broader downtrend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Want the complete AI research memo? Unlock full stock analysis →
Score breakdown
- Financial Quality
- 85
- Growth
- 48
- Profitability
- 75
- Balance Sheet
- 71
- Valuation
- 58
- Momentum
- 10
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 53.5%
- ROE
- 66.0%
- FCF Margin
- 24.6%
- Free Cash Flow (TTM)
- $1.1B
- Earnings Quality (OCF ÷ Net Income)
- 1.1x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- 36.2x
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- 1.6x
- Company Median PEG
- 1.6x
- Price / Sales
- 9.4x
- EV / EBITDA
- 26.0x
- FCF Yield
- 2.5%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $4.27
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-08-04
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-05-05
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-20
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-11-03
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-08-04
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-21
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-22
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-16
- 10-K · FY21 · period ended 2021-12-31Filed 2022-02-16
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $43.0B · 52-week range $518.55–$769.98 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2026-08-04
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze IDXX with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.